China Money Network
Login
Join

China’s Sunpower To Acquire Valeant’s US Biopharma Unit Dendreon For $819M

  • January 11, 2017 — 12:07 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese companies remain active buyers of overseas healthcare related assets. Privately owned conglomerate Sanpower Group has agreed to acquire Valeant’s biopharma unit Dendreon for US$819.9... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: